ATE250340T1 - 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele - Google Patents

7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele

Info

Publication number
ATE250340T1
ATE250340T1 AT98908734T AT98908734T ATE250340T1 AT E250340 T1 ATE250340 T1 AT E250340T1 AT 98908734 T AT98908734 T AT 98908734T AT 98908734 T AT98908734 T AT 98908734T AT E250340 T1 ATE250340 T1 AT E250340T1
Authority
AT
Austria
Prior art keywords
paclitaxele
methylthiooxomethyl
methylthiodioxomethyl
present
invention concerns
Prior art date
Application number
AT98908734T
Other languages
English (en)
Inventor
Jerzy Golik
Dolatrai M Vyas
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE250340T1 publication Critical patent/ATE250340T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98908734T 1997-02-28 1998-02-24 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele ATE250340T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3948097P 1997-02-28 1997-02-28
PCT/US1998/003741 WO1998037765A1 (en) 1997-02-28 1998-02-24 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels

Publications (1)

Publication Number Publication Date
ATE250340T1 true ATE250340T1 (de) 2003-10-15

Family

ID=21905699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98908734T ATE250340T1 (de) 1997-02-28 1998-02-24 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele

Country Status (11)

Country Link
US (1) US5902822A (de)
EP (1) EP1011329B1 (de)
JP (1) JP2001513778A (de)
AT (1) ATE250340T1 (de)
AU (1) AU724591B2 (de)
CA (1) CA2282264A1 (de)
DE (1) DE69818492T2 (de)
DK (1) DK1011329T3 (de)
ES (1) ES2207817T3 (de)
PT (1) PT1011329E (de)
WO (1) WO1998037765A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046904A1 (en) * 1998-03-12 1999-09-16 John Griffits Improved realtime internet functions by use of a hybrid pstn and ip protocol means
HK1049787B (en) 1999-10-01 2014-07-25 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AU7007001A (en) 2000-06-22 2002-01-02 Nitromed Inc Nitrosated and nitrosylated taxanes, compositions and methods of use
PL217731B1 (pl) 2006-06-01 2014-08-29 Tomasz Byrski Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi
MA38656A1 (fr) 2013-06-11 2018-05-31 Bayer Pharma AG Combinaisons pour le traitement du cancer comprenant un inhibiteur de la kinase mps-1 et un inhibiteur de la mitose

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
HU225474B1 (en) * 1991-09-23 2006-12-28 Univ Florida State New 10-desacetoxytaxol derivatives, pharmaceutical derivatives containing them and procedure for preparing them
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
JPH07505887A (ja) * 1992-04-17 1995-06-29 アボツト・ラボラトリーズ タキソール誘導体
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
CA2100808A1 (en) * 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
FR2697019B1 (fr) * 1992-10-15 1994-11-25 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
CA2109861C (en) * 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
WO1994014787A1 (en) * 1992-12-23 1994-07-07 Bristol-Myers Squibb Company Novel sidechain-bearing taxanes and intermediates thereof
US5646176A (en) * 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
CA2111527C (en) * 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethyl ethers of taxane derivatives
WO1994020485A1 (en) * 1993-03-05 1994-09-15 Florida State University Process for the preparation of 9-desoxotaxanes
US5703247A (en) * 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
IL127599A (en) * 1994-01-28 2004-06-01 Upjohn Co Process for preparing isotaxol analogs
US5767296A (en) * 1994-06-09 1998-06-16 Daiichi Pharmaceutical Co., Ltd. Deacetoxytaxol derivatives
DE69504843T2 (de) * 1994-06-28 1999-02-11 Pharmacia & Upjohn Co., Kalamazoo, Mich. 7-äther-taxol ähnliche verbindungen antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen
EP0773938B1 (de) * 1994-07-26 1999-02-03 INDENA S.p.A. Semisynthetisch taxal derivate mit antitumor wirkung
US6201140B1 (en) * 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives

Also Published As

Publication number Publication date
EP1011329B1 (de) 2003-09-24
EP1011329A1 (de) 2000-06-28
DK1011329T3 (da) 2003-12-22
CA2282264A1 (en) 1998-09-03
AU724591B2 (en) 2000-09-28
WO1998037765A1 (en) 1998-09-03
DE69818492D1 (en) 2003-10-30
ES2207817T3 (es) 2004-06-01
EP1011329A4 (de) 2000-07-26
US5902822A (en) 1999-05-11
PT1011329E (pt) 2004-01-30
AU6668698A (en) 1998-09-18
DE69818492T2 (de) 2004-07-22
JP2001513778A (ja) 2001-09-04

Similar Documents

Publication Publication Date Title
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
DK0971717T3 (da) Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE231872T1 (de) Thiazolopyrimidinderivate
NO943002D0 (no) Fosfono-oksymetyletere av taxanderivater
ID23374A (id) Halogenopirimidin
TR199901077A3 (tr) Ispençiyari formülasyonlar.
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
ES2181744T3 (es) Hidratos de paclitaxel cristalinos.
MX9601994A (es) Profarmacos de derivados de paclitaxel.
SE9904377D0 (sv) Pharmaceutical combinations
SE9802937D0 (sv) Novel compounds
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
AU4558201A (en) Taxane anticancer agents
MA26604A1 (fr) Compositions pharmaceutiques.
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
ECSP003536A (es) Derivados de rufomicina utiles como antibioticos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1011329

Country of ref document: EP

REN Ceased due to non-payment of the annual fee